AI Automation Value Creation and
ROI for Private Equity
Alt-Human, developed by AssetMax, provides private equity funds, portfolio companies, and sell-side advisors with a structured, proven approach to capturing measurable value from artificial intelligence. It combines agentic AI automation with a comprehensive AI strategy and governance framework — enabling both immediate financial impact and long-term scalability. Across the lifecycle, Alt-Human sizes automation upside in underwriting, turns value levers into Day-100 and Year-1 plans, delivers tracked EBITDA uplift during the Holding Period, and packages buyer-ready ROI evidence to support multiple expansion at Exit Readiness.
INTRO
Built for Investment Teams That Need Measurable AI-Driven Value Creation
What Alt-Human Delivers
Measure, model, and monetize automation potential with a structured AI value-creation framework
Quantify EBITDA impact during diligence using the “One-Person Company” benchmark
Combine agentic AI automation with AI strategy and governance for repeatable deployment
Produce exit-ready ROI packs and collateral that buyers can underwrite
From Origination to Exit:
Maximised Asset Value.
Alt-Human connects AI automation strategy, underwriting discipline, and execution tracking into a single value creation framework — translating automation initiatives into measurable EBITDA and buyer-ready ROI evidence.
Size Automation Upside Before You Bid
Identify operational and automation upside early to shape the equity story
Use the “One-Person Company” benchmark to size EBITDA impact, cost reductions, and scale efficiencies
Apply ROI reference bands tied to specific AI use cases (1–7x within 12 months, depending on application)
Strengthen IC discussions with quantified, defensible value levers
Alt-Human supports Pre-LOI Screening & IC Prep by quantifying automation potential before the deal is signed. Using structured benchmarks — including the “One-Person Company” model and ROI reference bands tied to specific AI use cases — teams can size EBITDA uplift, stress-test assumptions, and enter early IC conversations with a clearer, evidence-backed value-creation narrative.
Turn Value Levers Into Day-100 and Year-1 Plans
Translate automation opportunities into sequenced, executable initiatives
Define data, infrastructure, operating model, and governance requirements for scale
Align management and value-creation teams on priorities and accountability
Build a repeatable roadmap to avoid siloed pilots and accelerate value capture
As teams move from diligence into execution planning, Alt-Human turns identified value levers into aligned Day-100 and Year-1 plans. The framework pairs practical automation workstreams with an AI strategy and governance roadmap so initiatives can be executed safely, scaled across functions, and tracked against measurable outcomes.
Deliver EBITDA Through Agentic AI and Automation
Map where AI agents, automation, or workflow redesign can cut costs or increase throughput
Improve margins by eliminating inefficiencies while maintaining or improving output
Scale without adding proportional headcount to support profitable growth
Tie initiatives to measurable outcomes (cost savings, efficiency gains, revenue uplift) for board reporting
During the Holding Period, Alt-Human supports Value Creation Execution & Tracking by converting automation ideas into delivered EBITDA. It helps management identify high-impact opportunities, implement automation and workflow redesign, and measure results over time. By quantifying execution gains and remaining automation upside, it also enables evidence-based course correction — keeping the value-creation plan on track and board-ready.
Buyer-Ready ROI Evidence for Multiple Expansion
Convert automation improvements into quantified EBITDA and ROI evidence buyers underwrite
Deliver credible diligence collateral: AI strategy, roadmap, quantified ROI models, and governance policies
Strengthen the equity story by evidencing scalable efficiency and AI readiness
Reduce buyer skepticism and shorten diligence cycles with audit-ready documentation
At Exit Readiness, Alt-Human converts operational and automation progress into quantified EBITDA and ROI evidence that buyers value and underwrite. For management teams and sell-side advisors, the deliverables — including strategy, roadmap, ROI models, and governance documentation — strengthen the equity story, reduce follow-up diligence questions, and help protect valuation by turning AI-driven value creation into buyer-ready proof.
Turn AI automation into measurable EBITDA and buyer-ready ROI evidence.
WHY ALT-HUMAN
A Measurable AI Value Creation Engine — Not a Theoretical Framework
Alt-Human is designed for private equity operators who need measurable outcomes, not isolated pilots. It blends agentic automation delivery with a comprehensive strategy and governance framework so initiatives can be replicated across assets, tracked against EBITDA impact, and packaged into defensible buyer-ready evidence. The combination of ROI benchmarks, structured deployment models, and lifecycle integration ensures AI value creation is disciplined, repeatable, and directly linked to capital outcomes.
Structured, proven approach combining agentic AI automation with AI strategy and governance
ROI reference bands tied to AI use cases (1–7x within 12 months, depending on application)
Portfolio-wide repeatability via a structured AI strategy and deployment model
Deal Lifecycle Fit
Pre Deal
Automation sizing, IC-ready ROI modeling, underwriting support
Holding Period
Execution tracking, EBITDA delivery, automation scaling
Exit Readiness
Buyer-ready ROI evidence, equity story reinforcement